Swedbank
ABMD

Swedbank’s Abiomed Inc ABMD Stock Holding History

Swedbank’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-978
Closed -$240K – 747
2022
Q3 		$240K Sell
978
-2,515
-72% -$679K ﹤0.01% 713
2022
Q2 		$865K Hold
3,493
– – ﹤0.01% 653
2022
Q1 		$1.16M Hold
3,493
– – ﹤0.01% 664
2021
Q4 		$1.26M Hold
3,493
– – ﹤0.01% 675
2021
Q3 		$1.14M Hold
3,493
– – ﹤0.01% 681
2021
Q2 		$1.09M Hold
3,493
– – ﹤0.01% 684
2021
Q1 		$1.11M Buy
+3,493
New +$1.12M ﹤0.01% 670

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Swedbank's ABMD Position: Q4 2022 in Review

Swedbank sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 978 shares — an estimated $240K sold.

Swedbank first reported a position in ABMD in Q1 2021 and held it in 7 quarters. The position peaked at $1.26M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Swedbank reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Swedbank sold 978 Abiomed Inc shares in Q4 2022, an estimated $240K.
  • Swedbank first reported a position in Abiomed Inc in Q1 2021 and held it in 7 quarters.
  • Swedbank's Abiomed Inc position peaked at $1.26M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Swedbank's 13F filing for Q4 2022, filed 6 Dec 2024.